(Q33906773)

29 July 2017

1 reference

title

Interventions aimed at decreasing the risk of mother-to-child transmission of HIV infection (English)

1 reference

29 July 2017

0 references

0 references

P Brocklehurst

1

1 reference

29 July 2017

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

29 July 2017

1 reference

29 July 2017

CD000102

1 reference

29 July 2017

2

1 reference

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

29 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

Prevention of mother-to-child transmission of HIV in Africa: uptake of pregnant women in a clinical trial in Abidjan, Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

Risk of human immunodeficiency virus type 1 transmission through breastfeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

Maternal vitamin A deficiency and mother-to-child transmission of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

A survey of zidovudine use in pregnant women with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000102

10.1002/14651858.CD000102

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

0 references

1 reference

PubMed ID

10796128